Here, we designed an active targeting pH-sensitive RNP loaded with DOX by decorating an aptamer SL1 on RBC membranes (SL1-RNP-DOX) for c-Met-targeted therapy of GBM (Scheme 1). Here, MET is linked to glioblastoma.